Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
196 questions in 33 reviews · Urology
current versionsNo studies 196 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Transrectal thermotherapy vs medical treatment Adverse events ‐ not reported · participants with chronic prostatitis/chronic pelvic pain syndrome Non‐pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome (2018) · Cochrane | no estimate extracted | NR | No studies |
Transrectal thermotherapy vs medical treatment Sexual dysfunction ‐ not reported · participants with chronic prostatitis/chronic pelvic pain syndrome Non‐pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome (2018) · Cochrane | no estimate extracted | NR | No studies |
Transrectal thermotherapy vs medical treatment Quality of life ‐ not reported · participants with chronic prostatitis/chronic pelvic pain syndrome Non‐pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome (2018) · Cochrane | no estimate extracted | NR | No studies |
Transrectal thermotherapy vs medical treatment Depression and anxiety ‐ not reported · participants with chronic prostatitis/chronic pelvic pain syndrome Non‐pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome (2018) · Cochrane | no estimate extracted | NR | No studies |
Transrectal thermotherapy (add‐on) vs medical treatment alone Adverse events ‐ not reported · participants with chronic prostatitis/chronic pelvic pain syndrome Non‐pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome (2018) · Cochrane | no estimate extracted | NR | No studies |
Transrectal thermotherapy (add‐on) vs medical treatment alone Sexual dysfunction ‐ not reported · participants with chronic prostatitis/chronic pelvic pain syndrome Non‐pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome (2018) · Cochrane | no estimate extracted | NR | No studies |
Transrectal thermotherapy (add‐on) vs medical treatment alone Quality of life ‐ not reported · participants with chronic prostatitis/chronic pelvic pain syndrome Non‐pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome (2018) · Cochrane | no estimate extracted | NR | No studies |
Transrectal thermotherapy (add‐on) vs medical treatment alone Depression and anxiety ‐ not reported · participants with chronic prostatitis/chronic pelvic pain syndrome Non‐pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome (2018) · Cochrane | no estimate extracted | NR | No studies |
Acupuncture vs sham procedure Quality of life ‐ not reported · participants with chronic prostatitis/chronic pelvic pain syndrome Non‐pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome (2018) · Cochrane | no estimate extracted | NR | No studies |
Acupuncture vs sham procedure Depression and anxiety ‐ not reported · participants with chronic prostatitis/chronic pelvic pain syndrome Non‐pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome (2018) · Cochrane | no estimate extracted | NR | No studies |
Bisphosphonates vs placebo/no treatment Quality of life · men with advanced prostate cancer Bisphosphonates for advanced prostate cancer (2017) · Cochrane | no estimate extracted | NR | No studies |
Laparaoscopic radical prostatectomy and robotic‐assisted laparoscopic radical prostatectomy vs open radical prostatectomy Prostate cancer‐specific survival ‐ not reported Laparoscopic and robotic‐assisted versus open radical prostatectomy for the treatment of localised prostate… (2017) · Cochrane | no estimate extracted | NR | No studies |
Laparaoscopic radical prostatectomy and robotic‐assisted laparoscopic radical prostatectomy vs open radical prostatectomy Biochemical recurrence‐free survival ‐ not reported Laparoscopic and robotic‐assisted versus open radical prostatectomy for the treatment of localised prostate… (2017) · Cochrane | no estimate extracted | NR | No studies |
Laparaoscopic radical prostatectomy and robotic‐assisted laparoscopic radical prostatectomy vs open radical prostatectomy Overall survival ‐ not reported Laparoscopic and robotic‐assisted versus open radical prostatectomy for the treatment of localised prostate… (2017) · Cochrane | no estimate extracted | NR | No studies |
Potassium citrate vs no intervention Proportion of participants undergoing retreatment for urinary stones · children with idiopathic urinary calculi treated with shockwave lithotripsy Medical and dietary interventions for preventing recurrent urinary stones in children (2017) · Cochrane | no estimate extracted | NR | No studies |
Interferon‐α alone vs interferon‐α plus bevacizumab Quality of life · previously untreated patient with mRCC Immunotherapy for metastatic renal cell carcinoma (2017) · Cochrane | no estimate extracted | NR | No studies |
Interferon‐α plus bevacizumab vs standard targeted therapies Quality of life · previously untreated patients with mRCC Immunotherapy for metastatic renal cell carcinoma (2017) · Cochrane | no estimate extracted | NR | No studies |
Vaccine treatment vs standard therapies Quality of life · previously untreated patients with mRCC Immunotherapy for metastatic renal cell carcinoma (2017) · Cochrane | no estimate extracted | NR | No studies |
Interferon‐α combined with targeted therapies vs standard targeted therapy Quality of life · previously untreated patients with mRCC Immunotherapy for metastatic renal cell carcinoma (2017) · Cochrane | no estimate extracted | NR | No studies |
Postoperative MMC‐EMDA induction vs MMC‐PD induction therapy Disease‐specific quality of life ‐ not reported Intravesical electromotive drug administration for non‐muscle invasive bladder cancer (2017) · Cochrane | no estimate extracted | NR | No studies |
Postoperative MMC‐EMDA with sequential BCG induction and maintenance vs postoperative BCG induction and maintenance therapy Disease‐specific quality of life ‐ not reported Intravesical electromotive drug administration for non‐muscle invasive bladder cancer (2017) · Cochrane | no estimate extracted | NR | No studies |
Single‐dose, preoperative MMC‐EMDA vs single‐dose, postoperative MMC‐PD Disease‐specific quality of life ‐ not reported Intravesical electromotive drug administration for non‐muscle invasive bladder cancer (2017) · Cochrane | no estimate extracted | NR | No studies |
Single‐dose, preoperative MMC‐EMDA vs TURBT alone Disease‐specific quality of life ‐ not reported Intravesical electromotive drug administration for non‐muscle invasive bladder cancer (2017) · Cochrane | no estimate extracted | NR | No studies |
Postoperative MMC‐EMDA induction vs postoperative BCG induction therapy Disease‐specific quality of life ‐ not reported Intravesical electromotive drug administration for non‐muscle invasive bladder cancer (2017) · Cochrane | no estimate extracted | NR | No studies |
Partial nephrectomy vs radical nephrectomy Permanent haemodialysis ‐ not measured Partial nephrectomy versus radical nephrectomy for clinical localised renal masses (2017) · Cochrane | no estimate extracted | NR | No studies |
Partial nephrectomy vs radical nephrectomy Quality of Life ‐ not measured Partial nephrectomy versus radical nephrectomy for clinical localised renal masses (2017) · Cochrane | no estimate extracted | NR | No studies |
Desmopressin vs placebo Time to first void ‐ not reported Desmopressin for treating nocturia in men (2017) · Cochrane | no estimate extracted | NR | No studies |
Desmopressin vs behaviour modifications Number of nocturnal voids ‐ not reported Desmopressin for treating nocturia in men (2017) · Cochrane | no estimate extracted | NR | No studies |
Desmopressin vs behaviour modifications Quality of life ‐ not reported Desmopressin for treating nocturia in men (2017) · Cochrane | no estimate extracted | NR | No studies |
Desmopressin vs behaviour modifications Major adverse events ‐ not reported Desmopressin for treating nocturia in men (2017) · Cochrane | no estimate extracted | NR | No studies |
Desmopressin vs behaviour modifications Time to first void ‐ not reported Desmopressin for treating nocturia in men (2017) · Cochrane | no estimate extracted | NR | No studies |
Desmopressin vs placebo Quality of life ‐ not reported Desmopressin for treating nocturia in men (2017) · Cochrane | no estimate extracted | NR | No studies |
Desmopressin vs behaviour modifications Minor adverse events ‐ not reported Desmopressin for treating nocturia in men (2017) · Cochrane | no estimate extracted | NR | No studies |
Desmopressin vs behaviour modifications Treatment withdrawal due to adverse event ‐ not reported Desmopressin for treating nocturia in men (2017) · Cochrane | no estimate extracted | NR | No studies |
Desmopressin vs alpha‐blocker Duration of first sleep episode ‐ not reported Desmopressin for treating nocturia in men (2017) · Cochrane | no estimate extracted | NR | No studies |
Desmopressin vs alpha‐blocker Time to first void ‐ not reported Desmopressin for treating nocturia in men (2017) · Cochrane | no estimate extracted | NR | No studies |
Desmopressin plus alpha‐blocker vs alpha‐blocker Duration of first sleep episode ‐ not reported Desmopressin for treating nocturia in men (2017) · Cochrane | no estimate extracted | NR | No studies |
Desmopressin plus alpha‐blocker vs alpha‐blocker Time to first void ‐ not reported Desmopressin for treating nocturia in men (2017) · Cochrane | no estimate extracted | NR | No studies |
Desmopressin plus alpha‐blocker vs alpha‐blocker plus anticholinergic Quality of life ‐ not reported Desmopressin for treating nocturia in men (2017) · Cochrane | no estimate extracted | NR | No studies |
Desmopressin plus alpha‐blocker vs alpha‐blocker plus anticholinergic Duration of first sleep episode ‐ not reported Desmopressin for treating nocturia in men (2017) · Cochrane | no estimate extracted | NR | No studies |
Desmopressin plus alpha‐blocker vs alpha‐blocker plus anticholinergic Time to first void ‐ not reported Desmopressin for treating nocturia in men (2017) · Cochrane | no estimate extracted | NR | No studies |
Desmopressin vs placebo Quality of life ‐ not reported Desmopressin for treating nocturia in men (2017) · Cochrane | no estimate extracted | NR | No studies |
Intravesically administered BCG alternating with IFN‐α vs intravesically administered BCG alone Disease‐specific quality of life ‐ not measured · patients with non‐muscle invasive bladder cancer Intravesical Bacillus Calmette‐Guérin with interferon‐alpha versus intravesical Bacillus Calmette‐Guérin for… (2017) · Cochrane | no estimate extracted | NR | No studies |
Intravesically administered BCG combined with IFN‐α vs intravesically administered BCG alone Discontinuation of therapy due to adverse events ‐ not measured · patients with non‐muscle invasive bladder cancer Intravesical Bacillus Calmette‐Guérin with interferon‐alpha versus intravesical Bacillus Calmette‐Guérin for… (2017) · Cochrane | no estimate extracted | NR | No studies |
Intravesically administered BCG combined with IFN‐α vs intravesically administered BCG alone Disease‐specific quality of life ‐ not measured · patients with non‐muscle invasive bladder cancer Intravesical Bacillus Calmette‐Guérin with interferon‐alpha versus intravesical Bacillus Calmette‐Guérin for… (2017) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Outcomes1 · adult male patients Screening for prostate cancer (2013) · Cochrane | no estimate extracted | NR | No studies |